“…Oleuropein has been shown to reduce serum LDL (Jemai et al, 2008; A. Mahmoudi et al, ; Khalili et al, ; Lepore et al, ; F. Hadrich, Garcia, et al, ), TC (Jemai et al, 2008; A. Mahmoudi et al, ; Khalili et al, ; I. Andreadou et al, ; F. Hadrich, Garcia, et al, ; 246, Y. Oi‐Kano et al, ), and serum triglycerides (Jemai et al, 2008; A. Mahmoudi et al, ; Khalili et al, ; I. Andreadou et al, ; F. Hadrich, Garcia, et al, ; Y. Oi‐Kano et al, ) while also increasing serum HDL (Jemai et al, 2008; A. Mahmoudi et al, ; Khalili et al, ; F. Hadrich, Garcia, et al, ). In wild‐type mice, oleuropein caused reduction in serum TG and TC but not in PPAR‐α null mice showing that effect was due to activation and upregulation of PPAR‐α mRNA with an increase in multiple PPAR‐α target genes (Malliou et al, ). Furthermore, an in silico study showed that oleuropein was a PPAR‐α ligand that was corroborated with evidence of increased PPAR‐α and retinoid X receptor homodimerization.…”